Search
Amphastar Pharmaceuticals Inc
AMPHAdd to Watchlist
23.620USD
-0.200-0.84%
Close 09-18 16:00（ET）
1.00BMarket Cap
13.80P/E TTM
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Amphastar Pharmaceuticals Inc in the past month.
Hold
0 Strong Buy
0 Buy
6 Hold
1 Sell
0 Strong Sell
Target Price
22.500USD-4.82%
AMPH Analyst Recommendation Trends
In the current month, AMPH has received 0 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. AMPH average Analyst price target in the last month is 22.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
1
1
1
0
0
0
0
2
2
2
2
6
6
6
7
5
4
4
3
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
7
7
7
7
7
7
7
6
AMPH Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
9
21
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Financial Forecasting
Based on analysts' estimates, AMPH EPS is projected to reach 0.864 in FY2026Q3, following reported EPS of 0.695 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.92
0.70
0.62
0.86
0.80
Actual
0.53
0.14
0.70
--
--
Surprise
-42.30%
-79.91%
+12.13%
--
--
FAQs
What is Amphastar Pharmaceuticals Inc's expected revenue for the next quarter?
Amphastar Pharmaceuticals Inc's expected revenue is 197.85M.
What is Amphastar Pharmaceuticals Inc's price target?
Analysts forecast that Amphastar Pharmaceuticals Inc's price target is USD 22.50, with the highest forecast at USD 30.00 and the lowest forecast at USD 20.00.
How have Amphastar Pharmaceuticals IncAMPH's recent earnings per share performed?
The market expectation was USD 0.70, while Amphastar Pharmaceuticals IncAMPH's earnings per share (EPS) for the previous quarter was USD 0.14. EPS for the next quarter is expected at USD 0.86.
What is the analyst rating for Amphastar Pharmaceuticals Inc?
Based on the ratings of Amphastar Pharmaceuticals Inc's stock from 7 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.